237 related articles for article (PubMed ID: 18272685)
1. Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.
Kunz A; Abe T; Hochrainer K; Shimamura M; Anrather J; Racchumi G; Zhou P; Iadecola C
J Neurosci; 2008 Feb; 28(7):1649-58. PubMed ID: 18272685
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.
Caso JR; Pradillo JM; Hurtado O; Lorenzo P; Moro MA; Lizasoain I
Circulation; 2007 Mar; 115(12):1599-608. PubMed ID: 17372179
[TBL] [Abstract][Full Text] [Related]
3. Endothelial CD36 Contributes to Postischemic Brain Injury by Promoting Neutrophil Activation via CSF3.
Garcia-Bonilla L; Racchumi G; Murphy M; Anrather J; Iadecola C
J Neurosci; 2015 Nov; 35(44):14783-93. PubMed ID: 26538649
[TBL] [Abstract][Full Text] [Related]
4. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
[TBL] [Abstract][Full Text] [Related]
5. The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia.
Cho S; Park EM; Febbraio M; Anrather J; Park L; Racchumi G; Silverstein RL; Iadecola C
J Neurosci; 2005 Mar; 25(10):2504-12. PubMed ID: 15758158
[TBL] [Abstract][Full Text] [Related]
6. Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia.
Abe T; Shimamura M; Jackman K; Kurinami H; Anrather J; Zhou P; Iadecola C
Stroke; 2010 May; 41(5):898-904. PubMed ID: 20360550
[TBL] [Abstract][Full Text] [Related]
7. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury.
Park EM; Cho S; Frys KA; Glickstein SB; Zhou P; Anrather J; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 2006 Mar; 26(3):392-401. PubMed ID: 16049426
[TBL] [Abstract][Full Text] [Related]
9. Perillyl alcohol improves functional and histological outcomes against ischemia-reperfusion injury by attenuation of oxidative stress and repression of COX-2, NOS-2 and NF-κB in middle cerebral artery occlusion rats.
Tabassum R; Vaibhav K; Shrivastava P; Khan A; Ahmed ME; Ashafaq M; Khan MB; Islam F; Safhi MM; Islam F
Eur J Pharmacol; 2015 Jan; 747():190-9. PubMed ID: 25240714
[TBL] [Abstract][Full Text] [Related]
10. Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats.
Tu XK; Yang WZ; Wang CH; Shi SS; Zhang YL; Chen CM; Yang YK; Jin CD; Wen S
Inflammation; 2010 Oct; 33(5):344-52. PubMed ID: 20204486
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with rosuvastatin protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress and inflammation.
Ma M; Uekawa K; Hasegawa Y; Nakagawa T; Katayama T; Sueta D; Toyama K; Kataoka K; Koibuchi N; Kuratsu J; Kim-Mitsuyama S
Brain Res; 2013 Jun; 1519():87-94. PubMed ID: 23632378
[TBL] [Abstract][Full Text] [Related]
12. Role of microglial and endothelial CD36 in post-ischemic inflammasome activation and interleukin-1β-induced endothelial activation.
Garcia-Bonilla L; Sciortino R; Shahanoor Z; Racchumi G; Janakiraman M; Montaner J; Zhou P; Anrather J; Iadecola C
Brain Behav Immun; 2021 Jul; 95():489-501. PubMed ID: 33872708
[TBL] [Abstract][Full Text] [Related]
13. Sphingomyelin Synthase 2 Inhibition Ameliorates Cerebral Ischemic Reperfusion Injury Through Reducing the Recruitment of Toll-Like Receptor 4 to Lipid Rafts.
Xue J; Yu Y; Zhang X; Zhang C; Zhao Y; Liu B; Zhang L; Wang L; Chen R; Gao X; Jiao P; Song G; Jiang XC; Qin S
J Am Heart Assoc; 2019 Nov; 8(22):e012885. PubMed ID: 31718447
[TBL] [Abstract][Full Text] [Related]
14. Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPARγ/Nrf2/NF-κB signaling pathway.
Li Q; Tian Z; Wang M; Kou J; Wang C; Rong X; Li J; Xie X; Pang X
Int Immunopharmacol; 2019 Jan; 66():309-316. PubMed ID: 30502652
[TBL] [Abstract][Full Text] [Related]
15. Role of Neutrophils in Exacerbation of Brain Injury After Focal Cerebral Ischemia in Hyperlipidemic Mice.
Herz J; Sabellek P; Lane TE; Gunzer M; Hermann DM; Doeppner TR
Stroke; 2015 Oct; 46(10):2916-25. PubMed ID: 26337969
[TBL] [Abstract][Full Text] [Related]
16. 3,3'-Diindolylmethane inhibits lipopolysaccharide-induced microglial hyperactivation and attenuates brain inflammation.
Kim HW; Kim J; Kim J; Lee S; Choi BR; Han JS; Lee KW; Lee HJ
Toxicol Sci; 2014 Jan; 137(1):158-67. PubMed ID: 24162184
[TBL] [Abstract][Full Text] [Related]
17. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.
Zhang X; Polavarapu R; She H; Mao Z; Yepes M
Am J Pathol; 2007 Oct; 171(4):1281-90. PubMed ID: 17717150
[TBL] [Abstract][Full Text] [Related]
18. Small heterodimer partner attenuates hydrogen peroxide-induced expression of cyclooxygenase-2 and inducible nitric oxide synthase by suppression of activator protein-1 and nuclear factor-κB in renal proximal tubule epithelial cells.
Park JS; Choi HI; Bae EH; Ma SK; Kim SW
Int J Mol Med; 2017 Mar; 39(3):701-710. PubMed ID: 28204833
[TBL] [Abstract][Full Text] [Related]
19. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.
Nagayama M; Niwa K; Nagayama T; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 1999 Nov; 19(11):1213-9. PubMed ID: 10566967
[TBL] [Abstract][Full Text] [Related]
20. Humic acid in drinking well water induces inflammation through reactive oxygen species generation and activation of nuclear factor-κB/activator protein-1 signaling pathways: a possible role in atherosclerosis.
Hseu YC; Senthil Kumar KJ; Chen CS; Cho HJ; Lin SW; Shen PC; Lin CW; Lu FJ; Yang HL
Toxicol Appl Pharmacol; 2014 Jan; 274(2):249-62. PubMed ID: 24239652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
